http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02101629-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2299-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B15-20
filingDate 2002-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_175371dd9b65b7f838ab77233ae6bb96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ecc470806c30b876a5200d38c9ec581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f661a7760e3a6a1f6f4088c703c16261
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c205683df0bf48e96e3e01a6c1b6693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13ea98561832b01957111c063fb9cbdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7e05b4e8457c690f3a4b79e07754ecf
publicationDate 2002-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-02101629-A1
titleOfInvention Solution structure of il-13 and uses thereof
abstract The present invention relates to the three dimensional solution structure of interleukin-13 (IL-13), as well as the identification and characterization of various binding active sites of IL-13. Also provided for by the present invention are methods of utilizing the three dimensional structure for the design and selection of potent and selective agents that interact with IL-13.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020005819-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10703791-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8323646-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8399630-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7615213-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11401313-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005121177-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102827280-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10844105-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005121177-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020106708-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7501121-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11117944-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11655278-B2
priorityDate 2001-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6214559-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128833854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14264596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135894691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226457083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68290

Total number of triples: 53.